Fortress Biotech Inc

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative -12.91 M-19.56 M-27.56 M-6.11 M-12.54 M -65.78 M Flussi di cassa derivanti dalle attività di investimento -15 M1.17 M6.09 M2.87 M0 10.12 M Liquidità derivante dalle attività di finanziamento 25.81 M52.14 M4.52 M15.07 M5.71 M 77.44 M Liquidità libera -27.91 M-19.56 M-27.56 M-6.11 M-12.54 M -65.78 M

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

FBIO

Financials

Fortress Biotech Inc

Notizie

Avenue Therapeutics licenses ATX-04 for Pompe disease treatment

Fortress Biotech Stock: The PRV Catalyst That Could Reprice This Microcap (NASDAQ:FBIO)

Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums

Centene Expands Palliative Care Access in Ohio Through Tuesday Health

FDA approva il primo trattamento per la malattia di Menkes nei bambini

FDA approves first treatment for Menkes disease in children

La FDA fissa una nuova data PDUFA per la terapia di Fortress Biotech contro la malattia di Menkes

FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy

Fortress Biotech richiede la ripresentazione della NDA per il trattamento della malattia di Menkes

Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript